Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|April 1, 2003

The American Journal of Managed Care

April 2003
Volume 9
Issue 4

Pathophysiology and Management of Neurocardiogenic Syncope

Author(s)Nandini Nair, MD, PhD, Farooq A. Padder, MD, MRCP, Bharat K. Kantharia, MD, MRCP

Download PDF: Pathophysiology and Management of Neurocardiogenic Syncope

Articles in this issue

over 23 years ago

Article

Difference in the Use of Preventive Services Between Fee-for-Service Plans and HMOs: Is More Better?

over 23 years ago

Article

Prescription Drugs: Elderly Enrollee Reports of Financial Access, Receipt of Free Samples, and Discussion of Generic Equivalents Related to Type of Coverage

over 23 years ago

Article

Pediatric Combination Vaccines: Their Impact on Patients, Providers, Managed Care Organizations, and Manufacturers

over 23 years ago

Article

Restoring Trust to Managed Care, Part 3: A Focus on Public Stakeholders

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research managerial

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

AJMC Letter to the Editor

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

AJMC original research policy

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

AJMC commentary

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

AJMC commentary

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs

Remote Monitoring Captured Between-Visit Symptom Swings in Myasthenia Gravis

SNAP Participation Linked to Smaller Colorectal Screening Gap

Innovation Is Outpacing Reimbursement, Health System Execs Warn